Fingolimod 0.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FU170
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,682
Award facts
- Contract value 100% obligated
- $57,682.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $57,682.03 on November 25, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count packages). This competitively awarded, non-set-aside contract reflects firm fixed pricing and is scheduled for completion by November 26, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The Defense Logistics Agency's Medical Supply Chain relies on AmerisourceBergen as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. Fingolimod, a neurological treatment medication, represents one of the specialized pharmaceutical products within AmerisourceBergen's extensive federal contract portfolio, which encompasses diabetes medications, pain management pharmaceuticals, antibiotics, vaccines, and other medical commodities across multiple therapeutic domains. The company's demonstrated capability to fulfill federal medical supply requirements through open competition and its significant indefinite delivery contract position it as a key supplier for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FU170?
SPE2DR26FU170 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FU170 worth?
The government has obligated $57,682 on SPE2DR26FU170.
Is contract SPE2DR26FU170 an order under another contract?
Yes. SPE2DR26FU170 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU170 competed?
The extent of competition for SPE2DR26FU170 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award